Eyepoint Pharmaceuticals
EYPTInsider trades and stock quote 2022-2024
All insider trades at Eyepoint Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/18/2024 | Buy | Cormorant Asset Management, Lp | Ten Percent Owner | $18.3 | $10,489,446 |
| 2/2/2024 | Sell | Jones, David Scott | SVP & Chief Commercial Officer | $28.5 | $5,954 |
| 1/26/2024 | Sell | Jones, David Scott | SVP & Chief Commercial Officer | $25.4 | $660,370 |
| 1/26/2024 | Sell | Paggiarino, Dario A. | Chief Medical Officer | $25.5 | $1,265,540 |
| 1/25/2024 | Sell | Jones, David Scott | SVP & Chief Commercial Officer | $25.0 | $15,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)